27 Ken Griffin Corbus Pharmaceuticals Holdings Trades
The first Corbus Pharmaceuticals Holdings trade was made in Q4 2015.
Since then Ken Griffin bought shares 36 more times and sold shares on 38 occasions. The investor completely sold their stake between Q1 2023 and Q1 2023.
Avg closing price
Price range
Sold -229 shares
Q1 2023
Avg closing price
$4.37
Price range
$2.14
-
$8.83
New holding (+229 shares)
Q4 2022
Avg closing price
$3.85
Price range
$3.24
-
$5.84
Sold -2.3 Thousand shares
Q3 2022
Avg closing price
$7.05
Price range
$4.68
-
$9.02
Sold 3.4% shares (-80 shares)
Q2 2022
Avg closing price
$9.66
Price range
$6.30
-
$16.00
Sold 93.2% shares (-32.5 Thousand shares)
Q1 2022
Avg closing price
$13.25
Price range
$9.52
-
$19.97
Increased shares by 414.2% (+28.1 Thousand shares)
Q4 2021
Avg closing price
$27.08
Price range
$18.10
-
$33.30
Increased shares by 39.5% (+1.92 Thousand shares)
Q3 2021
Avg closing price
$39.44
Price range
$30.30
-
$54.60
Sold 20.2% shares (-1.23 Thousand shares)
Q2 2021
Avg closing price
$55.50
Price range
$41.70
-
$66.30
New holding (+6.1 Thousand shares)
Q1 2021
Avg closing price
$65.73
Price range
$38.10
-
$102.45
Sold -42.1 Thousand shares
Q3 2020
Avg closing price
$181.09
Price range
$45.15
-
$281.40
Sold 8.6% shares (-3.97 Thousand shares)
Q2 2020
Avg closing price
$202.06
Price range
$143.70
-
$251.70
Increased shares by 6837.5% (+45.4 Thousand shares)
Q1 2020
Avg closing price
$169.05
Price range
$103.20
-
$216.30
New holding (+664 shares)
Q4 2019
Avg closing price
$147.78
Price range
$128.70
-
$169.20
Sold -4.4 Thousand shares
Q2 2019
Avg closing price
$214.10
Price range
$198.00
-
$234.00
Increased shares by 12.8% (+500 shares)
Q1 2019
Avg closing price
$220.54
Price range
$172.80
-
$268.50
Increased shares by 214.7% (+2.66 Thousand shares)
Q4 2018